<?xml version="1.0" encoding="UTF-8"?>
<iati-activities>
 <iati-activity dstore:dataset="ifcwbg-cn" dstore:index="113" hierarchy="1" xml:lang="EN" xmlns:dstore="http://d-portal.org/xmlns/dstore">
  <iati-identifier>XM-DAC-903-SII-43968</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">RSE COVID Jointown</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">International Finance Corporation (IFC) is considering an investment in Jointown Pharmaceutical Group Co., Ltd. (the Company) to provide the Company with long-term funding to support the substantial increase in its working capital to procure pharmaceutical products and meet the surge in demand from health institutions for its distribution services. IFCs proposed investment will be a senior straight loan of RMB350 million.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">Project Outcome
Employees - Most of Jointown&apos;s warehouses and distribution centers are mainly located in frontier regions. While layoffs are being anticipated in a number of sectors in China in view of the worsening global economic conditions, Jointown will continue to hire more staff given the growing demand for health-related services, along with the coming on stream of its various new or upgraded facilities.

Contribution to Market Creation
Resilience - Health sector, specifically pharmaceutical distribution sub-sector, is the most needed sector during the COVID-19 pandemic. Jointown and peer companies play an important role in ensuring reliable and timely delivery services of essential supplies to hospitals and clinics, thereby supporting the healthcare system to be able to continue its operations.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JOINTOWN PHARMACEUTICAL GROUP CO., LTD.</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-43968" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-10-30" type="2"></activity-date>
  <activity-date iso-date="2020-05-29" type="1"></activity-date>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Jointown Pharmaceutical Group Co., Ltd  Ms. Yanling Cai  Supervisor  +86 10 60210837  Cyl_2009@163.com  Development Zone, Beijing, China  www.jztey.com</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">0  0  0  0  0  0  0  0  0.0000         &#xA0;  &#xA0;  &#xA0;  &#xA0;  &#xA0;  &#xA0;  No. 9   Guangping   Avenue,   Daxing   Economic Development Zone, Beijing, China</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="CN" percentage="100">
   <narrative xml:lang="EN">China</narrative>
  </recipient-country>
  <location ref="CN-China">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">Hubei Province, China</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>35.0000000000 105.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">other</narrative>
  </sector>
  <tag code="COVID-19" vocabulary="99"></tag>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $49.66 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2020-05-29"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2020-05-29">49660000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-05-29"></transaction-date>
   <value currency="USD" value-date="2020-05-29">49660000</value>
   <receiver-org>
    <narrative xml:lang="EN">JOINTOWN PHARMACEUTICAL GROUP CO., LTD.</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/#/projectDetail/SII/43968">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/#/projectDetail/SII/43968">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
